Publications by authors named "Anthony Conlon"

Claim this Profile
S
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial.
Rituparna Das, Daniel Blázquez-Gamero, David I Bernstein, Soren Gantt, Oliver Bautista, Anthony Conlon

Lancet Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
Stuart P Adler, Nicole Lewis, Anthony Conlon, Mark P Christiansen, Mohamed Al-Ibrahim

J Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis